• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • COPD Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: DenmarkChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Emerging Therapeutics: Addressing the Gaps in CSU Patient Care
Dermatology
10 min
expert video

Emerging Therapeutics: Addressing the Gaps in CSU Patient Care

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Pulmonology
3 min
Infographic

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients

The Burden in Patients with CRSwNP and Coexisting Asthma
Pulmonology
8 min
expert video

The Burden in Patients with CRSwNP and Coexisting Asthma

EoE Quest: Navigating the Patient Experience
Gastroenterology
12 min
interactivity

EoE Quest: Navigating the Patient Experience

ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions
Rhinology
16 min
expert video

ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions

Gastro Forum 2025 | EoE: How Far We've Come
Gastroenterology
24 min
videoanimation

Gastro Forum 2025 | EoE: How Far We've Come

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management
Pulmonology
5 min
interactivity

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

CSU is Unpredictable in its Course and Duration
Dermatology
3 min
expert video

CSU is Unpredictable in its Course and Duration

Expert Interview with Dr Jason Hawkes
Dermatology
3 min
expert video

Expert Interview with Dr Jason Hawkes

The Clinical Presentation of CSU is Heterogeneous
Dermatology
3 min
expert video

The Clinical Presentation of CSU is Heterogeneous

Type 2 Inflammation Contributes to Itch and Fibrois in PN
Dermatology
4 min
expert video

Type 2 Inflammation Contributes to Itch and Fibrois in PN

Expert Interview: Featuring Dr Shawn Kwatra on PN itch and impact on patients
Dermatology
2 min
expert video

Expert Interview: Featuring Dr Shawn Kwatra on PN itch and impact on patients

    1
    ...
    8910
    ...
    32